EndoVantage

EndoVantage

Clinicians with novel computational tools for the personalized planning of endovascular treatments.
  • Edit
DateInvestorsAmountRound
N/A

$450k

Convertible
*

N/A

Acquisition
Total Funding€409k

Recent News about EndoVantage

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.